Point Of Care Diagnostics Market Qualitative and Quantitative Analysis Report 2030

Increasing Adoption of P-o-C Diagnostics

The point-of-care diagnostics market is on the upswing, driven by the increasing demand for rapid diagnostic tests and technological advancements in performing point-of-care diagnostics. Conventional laboratory testing involves visiting a laboratory and providing samples, which is inconvenient for the elderly population or patients suffering from chronic disorders who need regular testing. The point-of-care diagnostics, however, can be administered at or near the site of patient care. While a 2020 UN report highlighted that the global population aged 65 and above was approximately 727 million, the number could reach over 1.5 billion by 2050, doubling from current figures.

Aging is linked to a higher prevalence of several diseases, including obesity and diabetes, which also raise the risk of infectious diseases. The elderly are particularly vulnerable to conditions, such as cancer, heart disease, obesity, neurological issues, and diabetes. Consequently, the increasing number of older adults worldwide is predicted to significantly drive market growth.

In addition, the increasing prevalence of genetic disorders is likely to drive the PoC diagnostics market in the coming years. In addition, the market is witnessing a surge in the adaptability of mobile diagnostic devices, particularly in middle-income countries, which is further propelling the market forward. The market size, valued at USD 44.24 billion in 2023, is projected to expand at a CAGR of 6.1% from 2024 to 2030. The POC diagnostics market is also likely to benefit from the increased funding from both government and private institutions aimed at accelerating the introduction of advanced diagnostic technologies.

Gather more insights about the market drivers, restrains and growth of the Point Of Care Diagnostics Market

Driving Factors of the POC Diagnostics Market

Rising Demand for Rapid Testing:

The increasing requirement for immediate diagnostic results is a key driver for the point-of-care diagnostics market. Healthcare professionals and patients both seek rapid tests that can be administered at or near the patient’s bedside. These tests enable timely decision-making, especially in critical situations. The demand for point-of-care (POC) diagnostics is further fueled by the prevalence of infectious diseases, where quick identification and containment are crucial. In addition, the convenience of POC tests, which eliminate the need for sending samples to centralized laboratories, appeals to both healthcare providers and patients.

Advancements in Technology and Mobile Devices:

The technological innovations have significantly enhanced POC diagnostics. Mobile diagnostic devices, such as handheld analyzers and smartphone-based testing platforms, are gaining prominence. These devices offer portability, ease of use, and connectivity, allowing healthcare professionals to perform tests in diverse settings. The adaptability of mobile POC devices is particularly beneficial in middle-income countries with limited access to centralized laboratories. As these technologies continue to evolve, they contribute to the market’s growth. Moreover, increased funding from government agencies and private investors supports research and development, leading to more accurate and efficient POC diagnostic solutions.

 

Recent Innovations

The POC diagnostics market has witnessed remarkable innovations driven by technological advancements. Continuous innovation in P-o-C diagnostics technologies is revolutionizing healthcare by enabling rapid, accurate, and patient-centric diagnostics at the point of care. These advancements contribute to better disease management, early intervention, and improved health outcomes for patients worldwide.

Biosensors: These devices enable rapid and sensitive detection of specific biomarkers, enhancing diagnostic accuracy. By leveraging bioreceptors and transducers, biosensors provide real-time results, making them invaluable for point-of-care testing.

Microfluidics: Miniaturized devices based on microfluidic principles allow precise manipulation of small volumes of fluids. These platforms facilitate efficient sample processing, reduce turnaround time, and enable faster disease diagnosis.

Lab-on-a-Chip Technologies: These integrated systems combine multiple functions, such as sample preparation, analysis, and detection, onto a single chip. Lab-on-a-chip devices are portable, cost-effective, and suitable for decentralized testing.

Other Technologies: Innovations in data analytics, connectivity, and cloud-based solutions enhance the overall POCD ecosystem. These technologies improve data management, remote monitoring, and decision-making for healthcare professionals.

Smartphone-Based Detection Platforms: These platforms turn mobile devices into diagnostic tools by utilizing smartphone cameras and apps. Users can perform tests and receive results directly on their phones, enhancing accessibility and convenience.

Nanoelectronic Biosensors: These ultra-sensitive sensors detect minute changes in biological molecules. Nanoelectronic biosensors hold promise for personalized medicine, allowing tailored treatment based on individual patient profiles.

Browse more reports published by Grand View Research.

• Robotaxi Market Size, Share & Trends Analysis Report By Propulsion (Electric, Fuel Cell), By Application (Goods Transportation, Passenger Transportation), By Component (Camera, RADAR, LiDAR), By Region, And Segment Forecasts, 2023 To 2030 

• 3D Printing Market Size, Share & Trends Analysis ReportBy Component (Hardware, Software, Services), By Printer Type, By Technology, By Software, By Application, By Vertical, By Region, And Segment Forecasts, 2024 – 2030

Major Market Players

Abbott, F. Hoffmann-La Roche Ltd., Inc., Siemens Healthcare GmbH, and Danaher Corporation are some of the leading companies leading innovations in the PoC diagnostics industry. In 2023, Cipla Limited, an Indian pharmaceutical company, introduced Cippoint, a Point-of-Care (POC) testing device. This device provides a comprehensive range of testing parameters, including infectious diseases, cardiac markers, fertility, diabetes, inflammation, coagulation markers, metabolic markers, and thyroid function.

In Conclusion

Continuous innovation in POCD technologies is revolutionizing healthcare by enabling rapid, accurate, and patient-centric diagnostics at the point of care. These advancements contribute to better disease management, early intervention, and improved health outcomes for patients worldwide.

About Grand View Research

Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.

Explore Horizon, the world’s most expansive market research database